Ogden Christopher sold CTMX
June 15, 2026 · Form 4 insider transaction
Ogden Christopher sold 1,624 shares of CytomX Therapeutics, Inc. at $3.05 per share, a transaction worth $5.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,624
Price
$3.05
Total value
$5.0K
InsiderOgden Christopher
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 15, 2026
Filing dateJune 17, 2026
Shares owned after295,324
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units ("RSUs").; Includes 167,249 RSUs.